Public Company News

FDA clears RF Medical's MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System

SEOUL, South Korea, Dec. 12, 2022 /PRNewswire/ -- RF Medical Co., Ltd. is a premier Korean-based medical company serving the healthcare industry for almost two decades. Recently, FDA cleared RF Medical's patented MYGEN™ M-3004 generator and MYOBLATE™ radiofrequency ablation system.

2024-01-26 15:26 1804

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

SHANGHAI, Jan. 26, 2024 /PRNewswire/ -- On January 17, 2024, Caocao Mobility and Cango embarked on a strategic partnership in smart mobility to explore areas including new car sales, used car transactions, financing services, and mobility offerings, marking the occasion with a signing ceremony. T...

2024-01-26 14:31 2844

LG Energy Solution Posts Steady Annual Growth, Aims for Continued Advancement Through Qualitative Growth

* LG Energy Solution marks KRW 33.7 trillion in consolidated revenue and KRW 2.2 trillion in operating profit in 2023 * To maintain growth momentum, the company to pursue qualitative growth by securing technology leadership, cost competitiveness and future readiness * This year's guidance fo...

2024-01-26 10:22 2876

TME Chart 2023 Year-End Charts Officially Unveiled, Featuring Notable Artists including Joker Xue, Zhou Shen and Tia Ray

SHENZHEN, China, Jan. 25, 2024 /PRNewswire/ -- TME Chart, one of the brand of Tencent Music Entertainment Group, officially released the TME Chart 2023 Year-End Charts onJanuary 23rd, featuring three main categories: General Chart, Uni Chart, and Wave Chart. A major overhaul characterized the 202...

2024-01-26 10:00 3708

Caravelle, a model of Sino-French co-operation, was praised by many media at the Davos Summit 2024

-- Wood drying ship spark in FoF (Fund of Funds) Forum at Davos SINGAPORE, Jan. 25, 2024 /PRNewswire/ -- Invited by the World Economic Forum, Caravelle's Chairman and CEO, DrGuohua Zhang, and the company's independent director, Dr.Alon Rozen, Dean of the Business School of École des Ponts ParisT...

2024-01-25 23:15 4912

Taoping Continues to Build Revenue Momentum With its Innovative Off-Grid Wastewater Treatment Solutions; New Project Completions and Order Pipeline Both Continue to Expand

SHENZHEN, China, Jan. 25, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a developer of innovative smart Cloud platform services and solutions, new media and artificial intelligence solutions, today announced that the Company's revenue momentum is being driven by increasing dema...

2024-01-25 21:50 2562

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

BEIJING, Jan. 25, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced its successful attainment of CE certification from the European Union for its full product portfolio of 14 charging pile...

2024-01-25 20:33 2389

Midea KWHA Showcases Energy-Efficient Whole-House Water and Heating Solutions at AHR Expo in Chicago

CHICAGO, Jan. 25, 2024 /PRNewswire/ -- Midea Kitchen and Water Heater Appliances Business Division (Midea KWHA) recently participated in the AHR Expo, a crucial event for HVACR professionals, held inChicago from January 22-24 . The AHR Expo unites manufacturers and suppliers of varying sizes and ...

2024-01-25 20:00 2702

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

LISHUI, China, Jan. 25, 2024 /PRNewswire/ -- Lixiang Education Holding Co., Ltd. (the "Company" or NASDAQ: LXEH), a prestigious private education service provider inChina, today announced that on January 24, 2024 it received a letter from the Nasdaq Hearing Panel (the "Panel"), notifying the Comp...

2024-01-25 20:00 3831

Emeren Group Announces Preliminary 2023 Financials and 2024 Outlook

STAMFORD, Conn., Jan. 25, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com ) (NYSE: SOL), a leading global solar project developer, owner, and operator, today provided a preliminary unaudited overview of its key financial results for the f...

2024-01-25 19:00 3970

Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World

* Glenmark will be responsible for further developing, registering, and commercializing Envafolimab inIndia, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America. * Jiangsu Alphamab and 3D Medicines will receive a low double digit Million US Dollar amount up to launch, additio...

2024-01-25 18:00 2485

TAL Education Group Announces Unaudited Financial Results for the Third Fiscal Quarter Ended November 30, 2023

BEIJING, Jan. 25, 2024 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced its unaudited financial results for the third quarter of fiscal year 2024 ended November 30, 2023. Highlights for the Third Quarter of Fisc...

2024-01-25 17:30 4178

Autohome Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on February 6, 2024

BEIJING, Jan. 25, 2024 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), a leading online destination for automobile consumers inChina, today announced that it will report its financial results for the fourth quarter and full year endedDecember 31, 2023, before...

2024-01-25 17:30 4028

Asieris will Present For the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU

SHANGHAI, Jan. 25, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the interi...

2024-01-25 16:56 2181

Yum China Announces Disclosure under Hong Kong Stock Exchange Rules in Relation to a Possible Quarterly Dividend

SHANGHAI, Jan. 25, 2024 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced, in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "HKEX") which require advance notice of boar...

2024-01-25 16:30 3788

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

SHANGHAI, Jan. 25, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading cognitive artificial intelligence ("AI") enterprise inChina, successfully held the signing ceremony for a strategic cooperation framework agreement with ABB Group (SIX: ABBN,"ABB") onN...

2024-01-25 16:06 2143

Planet Image International Limited Announces Pricing of Initial Public Offering

XINYU, China, Jan. 24, 2024 /PRNewswire/ -- Planet Image International Limited ("Planet Image" or the "Company") (Nasdaq: YIBO), an export-oriented manufacturer and seller of compatible toner cartridges based inChina, the U.S. andEurope, today announced the pricing of its initial public offering ...

2024-01-25 10:44 3919

AI and Robotics Brand UBTECH Showcases Innovations in AI Education at UK's BETT Show

LONDON, Jan. 24, 2024 /PRNewswire/ -- UBTECH(/'ju:bi:'tek/) (09880.HK), a leading AI and Robotics company with global recognition, made its debut at the British Educational Training and Technology Show (BETT) inLondon ,January 24-26 , showcasing its latest innovation in AI education. In recent yea...

2024-01-25 09:57 2463

WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect

-  WuXiaADCC PLUSTM is designed to meet the market need for improved antibody therapeutic efficacy by producing afucosylated antibodies with the ability to increase antibody-dependent cell-mediated cytotoxicity (ADCC), providing diverse bioprocessing solutions for global clients -  WuXiaADCC PLU...

2024-01-25 08:30 2605

SK hynix Reports Financial Results for 2023, 4Q23

- Reports first quarterly profit in a year, backed by demand recovery, industry rebound - Revenues for 2023 at 32.77 trillion won, operating loss at 7.73 trillion won - Aims to grow into 'total AI memory provider' of optimal memory solutions SEOUL, South Korea, Jan. 24, 2024 /PRNewswire/ -- SK hyn...

2024-01-25 07:30 4066
1 ... 307308309310311312313 ... 772